The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 501–600 of 1,644
Yamada, M., Ihara, M., Okamoto, Y., Maki, T., Washida, K., Kitamura, A., Hase, Y., Ito, H., Takao, K., Miyakawa, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016567 · Cited by 82
Hassing, L. B., Wåhlin, Å., Winblad, B. G., & Bäckman, L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00234-0 · Cited by 82
Dementia and Cerebrovascular Disease
Knopman, D. S. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.2.223 · Cited by 82
Fratini, M., Bukreeva, I., Campi, G., Brun, F., Tromba, G., Modregger, P., Bucci, D., Battaglia, G., Spanò, R., Mastrogiacomo, M., et al. (2015) · Scientific Reports · doi:10.1038/srep08514 · Cited by 81
Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment
Banerjee, G., Wilson, D., Jäger, H. R., & Werring, D. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.010 · Cited by 86
Neuroimaging in vascular cognitive impairment: a state-of-the-art review
Heiss, W., Rosenberg, G. A., Thiel, A., Berlot, R., & Reuck, J. D. (2016) · BMC Medicine · doi:10.1186/s12916-016-0725-0 · Cited by 86
“Heads Up” for Creatine Supplementation and its Potential Applications for Brain Health and Function
Candow, D. G., Forbes, S. C., Ostojić, S. M., Prokopidis, K., Stock, M. S., Harmon, K. K., & Faulkner, P. (2023) · Sports Medicine · doi:10.1007/s40279-023-01870-9 · Cited by 104
Brain atrophy and cognition: Interaction with cerebrovascular pathology?
Muller, M., Appelman, A. P. A., van der Graaf, Y., Vincken, K. L., Mali, W. P. T. M., & Geerlings, M. I. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.005 · Cited by 82
Saposnik, G., Kapral, M. K., Côté, R., Rochon, P. A., Wang, J., Raptis, S., Mamdani, M., & Black, S. E. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6508-4 · Cited by 81
Incidence of Dementia in Relation to Stroke and the Apolipoprotein E ε4 Allele in the Very Old
Zhu, L., Fratiglioni, L., Guo, Z., Basun, H., Corder, E. H., Winblad, B. G., & Viitanen, M. H. (2000) · Stroke · doi:10.1161/01.str.31.1.53 · Cited by 81
Rockwood, K. J., MacKnight, C., Wentzel, C., Black, S. E., Bouchard, R. W., Gauthier, S. G., Feldman, H., Hogan, D. B., Kertesz, A., Montgomery, P. R., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06408.x · Cited by 81
Patel, V., & Edison, P. (2024) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332661 · Cited by 80
Chua, T. C., Wen, W. X., Chen, X., Kochan, N. A., Slavin, M. J., Trollor, J. N., Brodaty, H., & Sachdev, P. S. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a76e0b · Cited by 80
Blumen, H. M., Allali, G., Beauchet, O., Lipton, R. B., & Verghese, J. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly158 · Cited by 80
Ghebremedhin, E., Rosenberger, A., Rüb, U., Vukšić, M., Berhe, T., Bickeböller, H., de Vos, R. A. I., Thal, D. R., & Deller, T. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d88e63 · Cited by 82
Wang, L., Du, Y., Wang, K., Xu, G., Luo, S., & He, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.006 · Cited by 81
SantaCruz, K. S., Sonnen, J. A., Pezhouh, M. K., Desrosiers, M. F., Nelson, P. T., & Tyas, S. L. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822e8ae9 · Cited by 79
Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population
Sigurdsson, S. O., Aspelund, T., Kjartansson, Ó., Gudmundsson, E. F., Jónsdóttir, M. K., Eiríksdóttir, G., Jónsson, P. V., van Buchem, M. A., Gudnason, V. G., & Launer, L. J. (2017) · Stroke · doi:10.1161/strokeaha.117.017357 · Cited by 79
The Links between Cardiovascular Diseases and Alzheimer's Disease
Leszek, J., Вячеславовна, М. Е., Belousov, D. M., Koutsouraki, E., Szczechowiak, K., Kobusiak−Prokopowicz, M., Mysiak, A., Diniz, B. S., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729093724 · Cited by 93
The Possible Role of Antioxidant Vitamin C in Alzheimer’s Disease Treatment and Prevention
Heo, J., Lee, H., & Lee, K. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512473193 · Cited by 79
Olfactory dysfunction in Alzheimer’s disease Systematic review and meta-analysis
Silva, M. D. M. E., Mercer, P. B. S., Witt, M. C. Z., & Pessoa, R. R. (2018) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn12-020004 · Cited by 86
Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage
Benedictus, M. R., Hochart, A., Rossi, C., Boulouis, G., Hénon, H., van der Flier, W. M., & Cordonnier, C. (2015) · Stroke · doi:10.1161/strokeaha.115.010200 · Cited by 78
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease
Silvestrini, M., Gobbi, B., Pasqualetti, P., Bartolini, M., Baruffaldi, R., Lanciotti, C., Cerqua, R., Altamura, C., Provinciali, L., & Vernieri, F. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.008 · Cited by 78
Midlife cardiovascular risk factors and late cognitive impairment
Virta, J. J., Heikkila, K. V., Perola, M., Koskenvuo, M. J., Räihä, I. J., Rinne, J. O., & Kaprio, J. A. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9794-y · Cited by 83
Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia
Mortamais, M., Artéro, S., & Ritchie, K. A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.838151 · Cited by 85
Interaction Between a Rat Model of Cerebral Ischemia and β-Amyloid Toxicity
Whitehead, S. N., Hachinski, V., & Cechetto, D. F. (2004) · Stroke · doi:10.1161/01.str.0000149627.30763.f9 · Cited by 77
Neuropsychological Impairment in Stroke, Carotid Stenosis, and Peripheral Vascular Disease
Rao, R., Jackson, S. H. D., & Howard, R. J. (1999) · Stroke · doi:10.1161/01.str.30.10.2167 · Cited by 77
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway
Kim, Y., Davidson, J. O., Gunn, K. C., Phillips, A. R. J., Green, C. R., & Gunn, A. J. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.12.001 · Cited by 76
The influence of age on the association between cholesterol and cognitive function
van Vliet, P., van de Water, W., de Craen, A. J. M., & Westendorp, R. G. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.004 · Cited by 82
Wyss‐Coray, T., Lin, C., Euw, D. V., Masliah, E., Mucke, L., & Lacombe, P. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06382.x · Cited by 76
Ogama, N., Sakurai, T., Shimizu, A., & Toba, K. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.004 · Cited by 75
APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke
Pendlebury, S. T., Poole, D. L., Burgess, A. I., DUERDEN, J. M., Rothwell, P. M., & Study, F. T. O. V. (2020) · Stroke · doi:10.1161/strokeaha.119.026927 · Cited by 80
Zuliani, G., Cavalieri, M., Galvani, M., Volpato, S., Cherubini, A., Bandinelli, S., Corsi, A., Lauretani, F., Guralnik, J. M., Fellin, R., et al. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq026 · Cited by 76
Jacobs, H. I. L., Visser, P. J., van Boxtel, M. P. J., Frisoni, G. B., Tsolaki, M., Papapostolou, P., Nobili, F. M., Wahlund, L., Minthon, L., Frölich, L., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.015 · Cited by 77
Which Vascular Lesions Are of Importance in Vascular Dementia?
Esiri, M. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06373.x · Cited by 75
Paris, D., Quadros, A., Humphrey, J., Patel, N. S., Crescentini, R. M., Crawford, F., & MULLAN, M. J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.061 · Cited by 75
Meng, Y., Baldwin, C. T., Bowirrat, A., Waraska, K., Inzelberg, R., Friedland, R. P., & Farrer, L. A. (2006) · The American Journal of Human Genetics · doi:10.1086/503687 · Cited by 72
Dermaut, B. (2001) · Brain · doi:10.1093/brain/124.12.2383 · Cited by 74
Health-Promoting Strategies for the Aging Brain
Chen, S. T., Volle, D. C., Jalil, J., Wu, P., & Small, G. W. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.12.016 · Cited by 75
Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia
Zuliani, G., Blè, A., Zanca, R., Munari, M. R., Zurlo, A., Vavalle, C., Atti, A. R., & Fellin, R. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.103005304.x · Cited by 74
Grau-Olivares, M., & Arboix, A. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.73 · Cited by 75
Coronary risk correlates with cerebral amyloid deposition
Reed, B., Marchant, N. L., Jagust, W. J., DeCarli, C. S., Mack, W. J., & Chui, H. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.002 · Cited by 74
Plasma folate concentration and cognitive performance: Rotterdam Scan Study
de Lau, L. M. L., Refsum, H., Smith, A. D., Johnston, C., & Breteler, M. M. B. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.728 · Cited by 75
Graff‐Radford, J. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000684 · Cited by 84
Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD
van der Flier, W. M., Middelkoop, H. A. M., Weverling‐Rijnsburger, A. W. E., Behloul, F., Spilt, A., Bollen, E. L. E. M., Westendorp, R. G. J., & van Buchem, M. A. (2004) · Neurology · doi:10.1212/01.wnl.0000125337.65553.8a · Cited by 74
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Saitô, S., & Ihara, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00290 · Cited by 77
Current Concepts of Analysis of Cerebral White Matter Hyperintensities on Magnetic Resonance Imaging
Yoshita, M., Fletcher, E. M., & DeCarli, C. S. (2005) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245456.98029.a8 · Cited by 76
Rincón, F., & Wright, C. B. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835c4f04 · Cited by 75
Incidence of stroke in people with Alzheimer disease
Tolppanen, A., Lavikainen, P., Solomon, A., Kivipelto, M., Soininen, H. S., & Hartikainen, S. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f08c5 · Cited by 75
Tau Protein Dysfunction after Brain Ischemia
Pluta, R. M., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180772 · Cited by 73
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
Burns, J. M., Honea, R. A., Vidoni, E. D., Hutfles, L. J., Brooks, W. M., & Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.011 · Cited by 74
Vascular Risk and Cognitive Impairment in an Older, British, African‐Caribbean Population
Stewart, R. J., Richards, M., Brayne, C., & MANN, A. H. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.4930263.x · Cited by 74
Shared genetic contribution to ischemic stroke and Alzheimer's disease
Traylor, M., Adib‐Samii, P., Harold, D., the Alzheimer's Disease Neuroimaging Initiative, T. I. S. G. C. (., Dichgans, M., Williams, J., Lewis, C. M., Markus, H. S., & and the METASTROKE and International Genomics of Alzheimer's Project (IGAP) investigators (2016) · Annals of Neurology · doi:10.1002/ana.24621 · Cited by 71
Vascular aspects in Alzheimer’s disease
Skoog, I. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_6 · Cited by 71
Quintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer’s Disease
Daulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0854-6 · Cited by 70
TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels
Laws, S. M., Perneczky, R., Wagenpfeil, S., Müller, U., Förstl, H., Martins, R. N., Kurz, A., & Riemenschneider, M. J. (2005) · Human Mutation · doi:10.1002/humu.20180 · Cited by 72
Javanshiri, K., Waldö, M. L., Friberg, N., Sjövall, F., Wickerström, K., Haglund, M., & Englund, E. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180644 · Cited by 68
Latimer, C. S., Keene, C. D., Flanagan, M. E., Hemmy, L. S., Lim, K. O., White, L. R., Montine, K. S., & Montine, T. J. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx030 · Cited by 73
Chronic cerebral hypoperfusion: An undefined, relevant entity
Ciacciarelli, A., Sette, G., Giubilei, F., & Orzi, F. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.01.026 · Cited by 70
New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection
Turner, A. J., & Nalivaeva, N. N. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82006-x · Cited by 71
Alzheimer's Disease prevalence, costs, and prevention for military personnel and veterans
Sibener, L., Zaganjor, I., Snyder, H. M., Bain, L. J., Egge, R., & Carrillo, M. C. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.011 · Cited by 69
Dementia: Alzheimer pathology and vascular factors: From mutually exclusive to interaction
van Norden, A. G. W., van Dijk, E. J., de Laat, K. F., Scheltens, P., Olde-Rikkert, M. G. M., & de Leeuw, F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.003 · Cited by 75
The Role of Cholesterol Metabolism in Alzheimer’s Disease
Sun, J.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8749-y · Cited by 70
Clinical Criteria for the Diagnosis of Alzheimer Disease: Still Good After All These Years
Ranginwala, N., Hynan, L. S., Weiner, M., & White, C. L. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181629971 · Cited by 70
Reiman, E. M., Chen, K., Langbaum, J. B. S., Lee, W., Reschke, C., Bandy, D. J., Alexander, G. E., & Caselli, R. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.025 · Cited by 73
Type 2 diabetes mellitus and cognition
Coker, L. H., & Shumaker, S. A. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00523-8 · Cited by 70
Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia
Solomon, A., Dobranici, L., Kåreholt, I., Tudose, C., & Lăzărescu, M. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2670 · Cited by 73
Sandberg, G., Stewart, W., Smialek, J., & Troncoso, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00236-0 · Cited by 68
Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia
Okamoto, Y., Ihara, M., Fujita, Y., Ito, H., Takahashi, R., & Tomimoto, H. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832d2e6a · Cited by 66
The role of inflammatory processes in Alzheimer’s disease
Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 71
Kim, Y. J., Kim, S. M., Jeong, D. H., Lee, S., Ahn, M., & Ryu, O. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00620-5 · Cited by 67
Shen, Q., Loewenstein, D., Potter, E., Zhao, W., Appel, J., Greig, M. T., Raj, A., Acevedo, A., Schofield, E., Barker, W., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.07.002 · Cited by 70
Kwok, T. C. Y., Lee, J., Ronald, C. W., Wong, S. Y. S., Kung, K., Lam, A. T., Ho, C. S., Lee, V. W. Y., Harrison, J., & LAM, L. C. W. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.10.018 · Cited by 68
Perry, H. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1369 · Cited by 65
Course and Causes of Suspected Dementia in Young Adults: A Longitudinal Study
Panegyres, P. K., & Frencham, K. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506295887 · Cited by 68
Pathological Aging of the Brain
de Bastos-Leite, A. J., Scheltens, P., & Barkhof, F. (2004) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000168070.90113.dc · Cited by 67
Jaworski, J., Figiel, I., Prószyński, T. J., & Kaczmarek, L. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6 · Cited by 9
The Renin Angiotensin System and Alzheimer's Disease
Amouyel, P., RICHARD, F., Berr, C., David-Fromentin, I., & Helbecque, N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06395.x · Cited by 68
Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia
Ye, B. S., Seo, S. W., Kim, J.-H., Kim, G. H., Cho, H., Noh, Y., Kim, H. J., Yoon, C. W., Woo, S.-Y., Kim, S. H., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002097 · Cited by 67
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease
Loeffler, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201182 · Cited by 71
Richard, E., Kuiper, R., Dijkgraaf, M. G. W., van Gool, W. A., & for the Evaluation of Vascular care in Alzheimer's disease Study Group (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02217.x · Cited by 67
Naismith, S. L., Glozier, N., Burke, D., Carter, P. E., Scott, E. M., & Hickie, I. B. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2008.00102.x · Cited by 69
Cerebrovascular Disease, Amyloid Plaques, and Dementia
Liu, W., Wong, A., Law, A. C. K., & Mok, V. (2015) · Stroke · doi:10.1161/strokeaha.114.006571 · Cited by 71
Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease
Li, J., Wang, Y., Zhang, M., Fang, C., & Zhou, H. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.04.024 · Cited by 68
The Initial Recognition and Diagnosis of Dementia
Knopman, D. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00022-9 · Cited by 67
Dementia diagnoses from clinical and neuropsychological data compared
Tschanz, J. T., Welsh-Bohmer, K. A., Skoog, I. G., West, N., Norton, M. C., Wyse, B. W., Nickles, R., & Breitner, J. C. S. (2000) · Neurology · doi:10.1212/wnl.54.6.1290 · Cited by 67
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.
Perry, G., Smith, M. A., McCann, C., Siedlak, S., Jones, P. K., & Friedland, R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00006-7 · Cited by 69
The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum
Au, R., Seshadri, S., Knox, K., Beiser, A., J. Himali, J., J. Cabral, H., Auerbach, S., C. Green, R., A. Wolf, P., & C. McKee, A. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322609 · Cited by 65
Microembolism, silent brain infarcts and dementia
Goldberg, I., Auriel, E., Russell, D., & Korczyn, A. D. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.02.021 · Cited by 68
Zheng, M., Qu, L., & Lou, Y. (2008) · Phytotherapy Research · doi:10.1002/ptr.2276 · Cited by 66
Advances in MRI Biomarkers for the Diagnosis of Alzheimer’s Disease
Kehoe, E. G., McNulty, J. P., Mullins, P. G., & Bokde, A. L. W. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.42 · Cited by 70
Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G. A., & Nagele, R. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160284 · Cited by 64
Effect of HMG-CoA Reductase Inhibitors on ??-Amyloid Peptide Levels
Höglund, K., & Blennow, K. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00002 · Cited by 63
Psychosocial competence of unselected young adults with sex chromosome abnormalities
Bender, B. G., Harmon, R. J., Linden, M. G., Bucher‐Bartelson, B., & Robinson, A. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990416)88:2 · Cited by 61
Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia
Kadir, A., & Nordberg, A. K. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077164 · Cited by 64
Alzheimer's disease with cerebrovascular disease: current status in the Asia–Pacific region
Chen, C., Homma, A., Mok, V., Krishnamoorthy, E. S., Alladi, S., Meguro, K., Abe, K., Dominguez, J. C., Marasigan, S., Kandiah, N., et al. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12495 · Cited by 65
The Role of Cerebrovascular Disease in Dementia
DeCarli, C. S. (2003) · The Neurologist · doi:10.1097/00127893-200305000-00001 · Cited by 64
White Matter Changes in Patients with Alzheimer’s Disease and Associated Factors
Kao, Y.-H., Chou, M., Chen, C., & Yang, Y. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020167 · Cited by 63
Hattori, Y., Okamoto, Y., Maki, T., Yamamoto, Y., Oishi, N., Yamahara, K., Nagatsuka, K., Takahashi, R., Kalaria, R. N., Fukuyama, H., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006265 · Cited by 64
Morphometry of the hippocampal microvasculature in post‐stroke and age‐related dementias
Burke, M. J. C., Nelson, L., Slade, J. Y., Oakley, A. E., Khundakar, A. A., & Kalaria, R. N. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12085 · Cited by 64
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
